Suven Pharmaceuticals Ltd Annually Results

Gross Sales

2,608.5

1,051.35

1,340.33

1,320.22

1,009.72

Excise Duty

0

0

0

0

0

Net Sales

2,608.5

1,051.35

1,340.33

1,320.22

1,009.72

Other Operating Income

0

0

0

0

0

Other Income

69.21

61.91

46.36

133.49

67.97

Total Income

2,677.71

1,113.26

1,386.69

1,453.71

1,077.69

Total Expenditure

1,827.22

645.54

766.17

740.8

569.24

PBIDT

850.49

467.72

620.53

712.92

508.45

Interest

41.06

7.45

12.81

6.23

9.14

PBDT

809.43

460.27

607.72

706.69

499.31

Depreciation

166.8

54.6

47.99

39.1

31.64

Minority Interest Before NP

0

0

0

0

0

Tax

172.28

98.8

144.1

190.4

101.72

Deferred Tax

-13.89

6.59

4.34

23.38

3.62

Reported Profit After Tax

484.24

300.28

411.29

453.8

362.34

Minority Interest After NP

-3.1

0

0

0

0

Net Profit after Minority Interest

487.34

300.28

411.29

453.8

362.34

Extra-ordinary Items

-11.55

0

0

0

0

Adjusted Profit After Extra-ordinary item

498.89

300.28

411.29

453.8

362.34

EPS (Unit Curr.)

12.79

11.8

16.16

17.83

14.23

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

600

500

200

Equity

25.46

25.46

25.46

25.46

25.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

32.6

44.48

46.29

54

50.35

PBDTM(%)

31.03

43.77

45.34

53.52

49.45

PATM(%)

18.56

28.56

30.68

34.37

35.88